Reports on HIV/AIDS: 1990

JANUARY 26, 1990, MMWR, Vol. 39, RR-1: [inclusive page numbers]
References
1. CDC. Recommendations for prevention of HIV transmission in health-care settings. MMWR
1987;36(no. 2S).
2. CDC. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.
MMWR 1988;37:377-88.
3. CDC. Guidelines for prevention of transmission of human immunodeficiency virus and
hepatitis B virus to health-care and public-safety workers. MMWR 1989;38(no. S-6).
4. CDC. 1988 Agent summary statement for human immunodeficiency virus and report on
laboratory-acquired infection with human immunodeficiency virus. MMWR 1988;37
(no. S-4).
5. US Department of Labor, US Department of Health and Human Services. Joint advisory
notice: protection against occupational exposure to hepatitis B virus (HBV) and human
immunodeficiency virus (HIV). Washington, DC: US Department of Labor, US Department of
Health and Human Services, 1987.
6. Henderson DK, Gerberding JL. Prophylactic zidovudine after occupational exposure to the
human immunodeficiency virus: an interim analysis. J Infect Dis 1989;160:321-7.
7. Marcus R, CDC Cooperative Needlestick Study Group. Surveillance of health-care workers
exposed to blood from patients infected with the human immunodeficiency virus. N EngI J
Med 1988;319:1118-23.
8. CDC. Recommendations for protection against viral hepatitis: recommendations of the
Immunization Practices Advisory Committee (ACIP). MMWR 1985;34:313-35.
9. CDC. Protection against viral hepatitis: recommendations of the Immunization Practices
Advisory Committee (ACIP). MMWR 1990 (in press).
10. CDC. Update on hepatitis B prevention. MMWR 1987;36:353-66.
11. CDC. Public Health Service guidelines for counseling and antibody testing to prevent HIV
infection and AIDS. MMWR 1987;36:509-15.
12. CDC. Additional recommendations to reduce sexual and drug abuse-related transmission of
human T-lymphotropic virus type Ill/lymphadenopathy-associated virus. MMWR 1986;
35:152-5.
13. CDC. Prevention of acquired immune deficiency syndrome (AIDS): report of inter-agency
recommendations. MMWR 1983;32:101-3.
14. CDC. Provisional Public Health Service inter-agency recommendations for screening donated blood and plalmra for antibody to the virus causing acquired immunodeficiency
syndrome. MMWR 1985;34:1-5.
15. Yarchoan R, Mitsuya H, Myers C, Broder S. Clinical pharmacology of 3'-azido-2', 3'dideoxythymidine (zidovudine) and related dideoxynucleosides. N EngI J Med 1989;
321:726-38.
16. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the
treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317:185-91.
17. Huff BB, ed. 1989 Physicians' desk reference. 43rd ed. Oradell, New Jersey: Edward R.
Barnhart, 1989:793-5.
18. Henderson DK, Fahey BJ, Saah AJ, Schmitt JM, Lane HC. Longitudinal assessment of risk for
occupational/nosocomial transmission of human immunodeficiency virus, type 1 in health
care workers [Abstract]. In: Program and abstracts of the twenty-eighth Interscience
Conference on Antimicrobial Agents and Chemotherapy (Los Angeles). Washington, DC:
American Society for Microbiology, 1988:221.
19. Gerberding JL, Littell CG, Chambers HF, et al. Risk of occupational HIV transmission in
intensively exposed health-care workers: follow-up [Abstract]. In: Program and abstracts of
the twenty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy (Los
Angeles). Washington, DC: American Society for Microbiology, 1988:169.
20. Elmslie K, Mulligan L, O'Shaughnessy M. National surveillance program: occupational
exposure to human immunodeficiency virus (HIV-1) infection in Canada. V International
Conference on AIDS. Montreal, June 4-9, 1989:148.
21. McEvoy M, Porter K, Mortimer P, Simmons N, Shanson D. Prospective study of clinical,
laboratory, and ancillary staff with accidental exposures to blood or body fluids from
patients infected with HIV. Br Med J 1987;294:1595-7.
22. Ruprecht RM, O'Brien LG, Rossoni LD, Nusinoff-Lehrman S. Suppression of mouse viraemia
and retroviral disease by 3'-azido-3'-deoxythymidine. Nature 1986;323:467-9.

16